3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Carcinoma, Non-Small-Cell Lung
8
Melanoma
7
Squamous Cell Carcinoma of Head and Neck
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Head and Neck Neoplasms
5
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Lymphoma
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Neoplasm Metastasis
2
Glioblastoma
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Microsatellite Instability
1
Interventions
Nivolumab
4
pertuzumab
2
pembrolizumab
2
durvalumab
2
Paclitaxel
2
Docetaxel
2
Capecitabine
2
ulocuplumab
1
tremelimumab
1
tazarotene
1
talazoparib
1
romiplostim
1
pexidartinib
1
pamiparib
1
onartuzumab
1
magrolimab
1
entrectinib
1
cobimetinib
1
atezolizumab
1
Sunitinib
1
Rifampin
1
Ramucirumab
1
Radiosurgery
1
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
1
Midazolam
1
MK-4166
1
LY3022855
1
LY2510924
1
LY-2157299
1
Itraconazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumor
×
epacadostat
×
Clear all
No trials found.